We need to do more research to find ways to help manage weight gain and reduce risks during pregnancy when stopping GLP-1 medications," she said
Other indicators include pain that radiates down your leg or into your buttock, numbness or tingling in your lower extremities, back pain that disrupts your sleep, difficulty performing routine daily activities like getting dressed or walking, and pain that worsens rather than improves over time
Theyre both approved to treat type 2 diabetes, and each have twin medicines approved for weight loss
Rapid adipocyte volume reduction from metabolic peptide research can outpace the rate of fibroblast-driven collagen remodeling, a phenomenon explored in our companion article on GLP-1 agonists and tissue laxity
(September 28, 2019) Efficacy and Safety of Ashwagandha (Withania somnifera) Root Extract in Insomnia and Anxiety: A Double-blind, Randomized, Placebo-controlled Study
When GLP 1 is not an option: alternatives that still move the needle For patients with contraindications, we design personalized plans using non GLP peptides, metabolic support strategies, or regenerative approaches that still move the needle safely
